Method for preparing tomato ago2b gene knockout mutant and application thereof in resisting tylcv
By knocking out the AGO2b gene in tomato using CRISPR/Cas9 technology, the problem of TYLCV control was solved, achieving highly efficient enhancement of tomato's resistance to the virus and a new breeding approach, providing stable disease-resistant mutant materials.
Patent Information
- Application Number
- CN202611483589.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-09-22
- Publication Date
- 2026-11-10
AI Technical Summary
Existing technologies are insufficient to effectively control tomato yellow leaf curl virus (TYLCV), and traditional methods such as breeding disease-resistant varieties and using pesticides have problems such as long cycles, high costs, and environmental pollution.
The AGO2b gene in tomato was knocked out using CRISPR/Cas9 gene editing technology. A recombinant vector was constructed by designing sgRNA target sequences and introduced into tomatoes to screen for homozygous mutants of the AGO2b gene, thereby enhancing the resistance of tomatoes to TYLCV.
It significantly reduces the accumulation of TYLCV and TYLCV-ΔV2 viral DNA, improves the resistance of tomatoes to viruses, and does not affect the normal growth and development of plants, providing new targets and germplasm resources for disease resistance breeding.
Smart Images

Figure CN123063441A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of genetic engineering technology, specifically to a tomato AGO2b Methods for preparing gene knockout mutants and their application in resistance to Tomato Yellow Leaf Curl Virus (TYLCV). Background Technology
[0002] Tomato yellow leaf curl virus (TYLCV) belongs to the Geminiviridae family ( Geminiviridae ), Bean Golden Mosaic Virus ( Begomovirus TYLCV (Tomato Yellow Leaf Curl), transmitted persistently by whiteflies, is the world's third most dangerous plant virus. Infecting tomatoes causes yellowing and curling of the leaf margins at the top of the plant, smaller and wrinkled leaves, slow plant growth, shortened internodes, significant stunting, reduced flower set, delayed flowering, reduced fruit set, and small, hard fruits. In my country, TYLCV-induced tomato yellow leaf curl has occurred in 34 provinces, municipalities, and autonomous regions, resulting in an average yield reduction of 20%-30% in affected fields, and even total crop failure in severely affected areas. This disease has become a major bottleneck hindering the high-quality development of the tomato industry.
[0003] Currently, the main methods for controlling TYLCV-induced diseases in production include breeding disease-resistant varieties, strengthening field management, and implementing pest and disease control measures. However, with the continuous emergence of new TYLCV isolates, the resistance of some existing Ty-resistant varieties has been overcome, and the process of discovering new disease-resistant genes and breeding new disease-resistant varieties is lengthy. Furthermore, the continued strengthening of the global greenhouse effect has led to an ever-growing whitefly population, making it increasingly difficult to eliminate whiteflies with insecticides, and resulting in problems such as increased whitefly resistance, environmental pollution from insecticides, and negative impacts on human health. Therefore, there is an urgent need to find safer, faster, and more effective measures to control TYLCV-induced diseases.
[0004] CRISPR / Cas9 is a powerful and precise genome editing technology. This technology has not only enabled the de novo domestication and introduction of desirable traits from wild tomato relatives into cultivated tomatoes, but also achieved reverse genetic improvement, rapidly and efficiently overcoming the technical barriers in tomato breeding. Currently, CRISPR / Cas9 technology has been used to successfully edit and identify the functions of various genes in tomatoes, including those related to plant morphology and floral organ characteristics, fruit ripening process, quality and nutrient composition, tolerance to abiotic stresses, carbon and nitrogen metabolic pathways, and herbicide resistance. Therefore, using CRISPR / Cas9 gene editing technology to improve tomato resistance to TYLCV not only helps overcome the severe constraints of tomato yellow leaf curl disease on the tomato industry, but also provides a new and effective approach for disease-resistant breeding.
[0005] It should be noted that the information disclosed in the background section above is only used to enhance the understanding of the background of this disclosure, and therefore may include information that does not constitute prior art known to those skilled in the art. Summary of the Invention
[0006] The purpose of this invention is to provide a tomato AGO2b The application of genes in regulating TYLCV resistance in tomatoes also provides a... AGO2b The method of cultivating gene knockout transgenic lines provides new targets and germplasm resources for effectively reducing the accumulation of tomato yellow leaf curl virus in tomatoes and for breeding tomato disease resistance.
[0007] To achieve the above objectives, the present invention provides a tomato AGO2b Application of the gene in resistance to Tomato Yellow Leaf Curl Virus (TYLCV); wherein, the... AGO2b The gene is a disease-susceptibility gene; reduce or knock out the aforementioned gene. AGO2b The expression of the gene can enhance the resistance of tomatoes to TYLCV. AGO2b The CDS sequence of the gene is shown in SEQ ID NO.1.
[0008] Preferably, the TYLCV used in the application includes wild-type TYLCV and / or the VSR-deficient mutant TYLCV-ΔV2.
[0009] The present invention also provides a tomato AGO2b The method for preparing gene knockout mutants includes the following steps: (1) For tomatoes AGO2b Design sgRNA target sequences from gene CDS regions; (2) The sgRNA target sequence is constructed into a knockout vector to obtain a recombinant vector; (3) The recombinant vector was introduced into tomatoes; (4) Screening AGO2b Genetically modified tomato plants with edited genes were screened to obtain homozygous mutants; Among them, the AGO2b The CDS sequence of the gene is shown in SEQ ID NO.1.
[0010] Preferably, the sgRNA target in the preparation method includes the sequences shown in SEQ ID NO.2, SEQ ID NO.3 and / or SEQ ID NO.5.
[0011] Preferably, the knockout vector in step (2) of the preparation method is selected from pHEE401.
[0012] Preferably, the sgRNA target in step (2) of the preparation method is constructed using primers AGO2b-DT1-BsF and AGO2b-DT1-BsR, whose nucleotide sequences are shown in SEQ ID NO.6 and SEQ ID NO.9, respectively.
[0013] Preferably, in step (3) of the preparation method, the recombinant vector is introduced into tomatoes via Agrobacterium. More preferably, Agrobacterium is selected from GV3101.
[0014] Preferably, the screening in step (4) of the preparation method includes the following steps: (a) PCR detection of transgenic plants was performed using primer pair Cas9-F / R, the nucleotide sequences of which are shown in SEQ ID NO.16 and SEQ ID NO.17; (b) Select plants from the T1 generation population that do not contain the exogenous Cas9 fragment; (c) PCR amplification and sequencing were performed using primer pairs AGO2b-detect-F / R and AGO2ab-2b-detect-F / R, and the nucleotide sequences of the primers are shown in SEQ ID NO.18, SEQ ID NO.19, SEQ ID NO.22 and SEQ ID NO.23, respectively; (d) Screening AGO2b Homozygous mutant plants with edited genes.
[0015] The present invention also provides a method for obtaining a product by the above preparation method. AGO2b The gene knockout mutant can also be used in TYLCV resistance breeding, and the mutant has significantly enhanced resistance to the viruses TYLCV and / or TYLCV-ΔV2.
[0016] The present invention has the following advantages: This invention is demonstrated through CRISPR / Cas9 knockout experiments. AGO2b It is a negative regulator in the tomato anti-TYLCV immune pathway, and knockout of it significantly reduces the accumulation of TYLCV and TYLCV-ΔV2 viral DNA.
[0017] This invention, through screening and identification, obtains exogenous fragments that do not contain Cas9. AGO2b The homozygous edited mutants MT-ago2b-281 and MT-ago2b-620.
[0018] In this invention, inoculation of the ago2b mutant with TYLCV resulted in significantly milder symptoms and a significantly reduced viral accumulation compared to the wild type. Simultaneously, plant height, leaf morphology, floral organ structure, and fruit development showed no significant differences compared to the wild type, indicating that knockout... AGO2bIt does not affect the normal growth and development of tomatoes.
[0019] This invention provides a complete set of sgRNA targets, recombinant vectors, transformation methods, and matching detection primers, with high reproducibility, providing new gene targets and germplasm materials for molecular breeding of tomatoes resistant to TYLCV. Attached Figure Description
[0020] Figure 1 For tomatoes AGO2b A schematic diagram illustrating the construction of a gene knockout vector and the knockout mutant; among which... Figure 1 A in the text is AGO2b A schematic diagram of gene targets; yellow represents the first target sequence; red represents the second target sequence; blue boxes represent exons, and broken lines represent introns; B represents... AGO2ab A schematic diagram of gene targets, with yellow indicating... AGO2a Target sequence; red indicates AGO2b Target sequence; blue boxes indicate exons, and broken lines indicate introns; C is a schematic diagram of the pHEE401 vector; 35Sp is the cauliflower mosaic virus 35S promoter, driving the expression of the Hygmycin resistance gene; the EC1.2p promoter drives the zCas9 gene for Cas9 expression in germ cells; two sgRNA expression cassettes driven by the U6-26p promoter are tandemly linked to achieve dual-target editing; SmR is a bacterial selection marker that is not transferred into plants.
[0021] Figure 2 For tomatoes AGO2b Gene knockout mutation types and mutant phenotypes; where A represents... MT-ago2b-281 mutant AGO2b Gene mutation information and Sanger sequencing results; blue represents amino acid changes; B represents... MT- ago2b-620 mutant AGO2b Gene mutation information and Sanger sequencing results, with blue indicating amino acid changes; where C represents... MT-ago2b The mutant plant phenotype was obtained from a 21-day-old tomato plant, with flowers and fruits collected from a 3-month-old tomato plant.
[0022] Figure 3 For tomatoes AGO2b Results of resistance testing of gene knockout enhanced mutant plants to TYLCV and TYLCV-ΔV2; among which, Figure 3Figure A shows the symptoms of TYLCV and TYLCV-ΔV2 in tomatoes 21 days after inoculation with different genotypes. MOCK represents a healthy control treated with immersion buffer. Figure B shows the accumulation of TYLCV in different genotypes of tomatoes 21 days after TYLCV infection using Southern blot analysis. Figure C shows the detection bands and quantitative results of TYLCV-ΔV2 accumulation in different genotypes of two mutant tomatoes 21 days after TYLCV-ΔV2 infection using Southern blot analysis. Total DNA is the DNA loading control, SC is the supercoiled DNA conformation of the virus, SS is the single-stranded DNA conformation of the virus, Loading is the loading control, and the viral DNA content value is the grayscale ratio to Total DNA. The bar chart represents MT-WT. ago2b-281 and ago2b-620 A statistical graph showing the differences in viral accumulation among mutants is provided. Error bars represent the standard deviations of three biological replicates, and asterisks indicate statistically significant differences. p<0.01, p<0.001). Detailed Implementation
[0023] The technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.
[0024] Note: Unless otherwise specified, the experimental procedures involved in this embodiment, including gene manipulation, plant genetic transformation, virus infection, and functional identification, all employ conventional standard techniques in the field and can be performed with reference to existing publicly available literature and product instructions. The strains, vectors, reagents, and experimental consumables used in this study are all commercially available products that can be routinely obtained through commercial channels.
[0025] Example 1 Tomato AGO2b Preparation method and functional verification of gene knockout mutants This embodiment utilizes the CRISPR / Cas9 gene editing system to construct tomatoes. AGO2b Homozygous knockout mutant material was used to analyze the regulatory function of this gene in tomato resistance to Tomato Yellow Leaf Curl Virus (TYLCV) infection. The specific operation is as follows: (1) According to reports, it has been confirmed AGO2 The gene has two homologous genes, namely AGO2a and AGO2b . AGO2a Depend onSolyc02g069260 coding, AGO2b Depend on Solyc02g069270 coding. AGO2a The open coding frame length is 3129 bp, encoding 1042 amino acids; AGO2b The open coding frame is 2934 bp long and encodes 977 amino acids, of which, AGO2b The CDS sequence of the gene is shown in SEQ ID NO.1. To obtain double mutants of AGO2b and AGO2a, a single mutant of AGO2b, and a single mutant of AGO2a in one step, sgRNA target sequences were screened using online bioinformatics tools (CCTop and Cas-OFFinder), resulting in three sequences located in... AGO2b The specific sgRNA target sequence of the first exon of the gene and a specific sgRNA target sequence located in the first exon of the AGO2a gene are illustrated in the following diagrams, along with their physical locations within the gene. Figure 1 As shown in A and B. This study designed two sets of sgRNA combinations: the first set consisted of two... AGO2b Specific targets for constructing ago2b Single knockout vectors are expected to result in either two target sites or one target site being edited. ago2b Mutant; the second set consists of 1 line AGO2a Target and 1 line AGO2b Target pairing, construction ago2ab The dual knockout vector is expected to yield the desired result. ago2ab Double mutation or ago2a and ago2b Single mutant plant. The two sets of target sequences are shown in SEQ ID NO.2-5, respectively; AGO2b Gene CDS sequence (SEQ ID NO.1): AGO2b DT1 (SEQ ID NO.2): GTGAGCTCCGCCGGGTCG; AGO2b DT2 (SEQ ID NO.3):GTGGGTGGTAACGCTTGGCAA; AGO2a DT1 (SEQ ID NO.4):GGTCTGACGGGGAAGATGCT; AGO2b DT3 (SEQ ID NO. 5): GACCGTGGAAACTACCAACG.
[0026] (2) Design primers for PCR amplification to obtain sequences containing the above 4 sgRNAs. The corresponding amplification primers are AGO2b-DT1-BsF, AGO2b-DT1-F0, AGO2b-DT2-R0, AGO2b-DT2-BsR, AGO2a-DT1-BsF, AGO2a-DT1-F0, AGO2b-DT3-R0 and AGO2b-DT3-BsR, and the sequences are shown in SEQ ID NO.6-13. AGO2b-DT1-BsF (SEQ ID NO.6): ATATATGGTCTCGATTGGTGGAGCTCCGCCGGGTCGGTT; AGO2b-DT1-F0 (SEQ ID NO.7): TGGTGGAGCTCCGCCGGGTCGGTTTTAGAGCTAGAAATAGC; AGO2b-DT2-R0 (SEQ ID NO.8): AACTTGCCAAGCGTTACCACCACAATCTCTTAGTCGACTCTAC; AGO2b-DT2-BsR (SEQ ID NO.9): ATTATTGGTCTCGAAACTTGCCAAGCGTTACCACCACAA; AGO2a-DT1-BsF (SEQ ID NO.10): ATATATGGTCTCGATTGGTCTGACGGGGAAGATGCTGTT; AGO2a-DT1-F0 (SEQ ID NO.11): TGGTCTGACGGGGAAGATGCTGTTTTAGAGCTAGAAATAGC; AGO2b-DT3-R0 (SEQ ID NO.12): AACCGTTGGTAGTTTCCACGGTCAATCTCTTAGTCGACTCTAC; AGO2b-DT3-BsR (SEQ ID NO.13): ATTATTGGTCTCGAAACCGTTGGTAGTTTCCACGGTCAA.
[0027] (3) The obtained sequence was inserted into the pHEE401 binary vector backbone using the BsaI restriction site to obtain the pHEE401-AGO2b and pHEE401-AGO2ab recombinant plasmids. Figure 1 As shown in C, the pHEE401 vector carries a codon-optimized zCas9 gene, a hygromycin resistance selection marker, and contains the tomato U6 promoter to drive sgRNA transcription.
[0028] (4) Recombinant plasmids pHEE401-AGO2b and pHEE401-AGO2ab were transformed into Agrobacterium GV3101 by heat shock. The bacterial culture was spread on the resistance medium and incubated at 28°C for 48 hours. The universal identification primer U6-26p, which is matched with the pHEE401 backbone, was used. F、U6-29p R is the amplification primer, and a colony PCR amplification system is used to screen positive clones of Agrobacterium single colonies; among them, U6-26p F and U6-29p The R nucleotide sequences are shown in SEQ ID NO.14-15, respectively; U6-26p F (SEQ ID NO. 14): TGTCCCAGGATTAGAATGATTAGGC; U6-29p R (SEQ ID NO. 15): AGCCCTCTCTCTTTCGATCCATCAAC.
[0029] (5) The selected positive Agrobacterium was inoculated into LB liquid medium (28℃, 220 rpm) and cultured with shaking until the late logarithmic growth phase (OD). 600 (Approximately 0.8-1.0), collect bacterial cells by centrifugation, resuspend in MS liquid resuspension buffer, and adjust the bacterial concentration to OD. 600 =0.8, activated at room temperature for 3 h.
[0030] (6) Select cotyledons of Micro-Tom tomato sterile seedlings grown in a sterile environment as explants, cut them into tissue blocks of about 0.5cm×0.5cm, and treat them in the dark on a pre-medium for 2 days. Then, completely immerse the explants in activated Agrobacterium bacterial solution for 10 min, blot dry the residual bacterial solution on the surface with filter paper, and transfer them to a co-medium for dark culture for 2 days. After co-culture, transfer the explants to a callus induction medium containing screening reagents for light culture. When adventitious buds are induced and elongated to about 1.5cm, cut off the buds and transfer them to a rooting medium until fully developed T0 generation regenerated plants are obtained.
[0031] (7) After the T0 generation plants have stabilized, the genomic DNA of the leaves of the T0 generation tomato regenerated plants was extracted in batches using the CTAB extraction method, and the vector-specific primer U6-26p was selected. F、U6-29p R was used for PCR amplification, and the amplification products were detected by electrophoresis. All plants that could amplify a specific band of about 700 bp were identified as positive transformants. The results showed that a band of about 700 bp was amplified in the T0 generation tissue culture seedlings of pHEE401-AGO2b with 9 lines, and a band of about 700 bp was amplified in the T0 generation tissue culture seedlings of pHEE401-AGO2ab with 9 lines. Therefore, 9 lines were identified in each of the T0 generation transgenic plants transformed with pHEE401-AGO2b and those transformed with pHEE401-AGO2ab recombinant plasmids.
[0032] (8) Collect seeds of T0 generation positive transformants and propagate them to T1 generation. Use Cas9-F / R specific primers to detect whether the T1 generation plants contain recombinant plasmids by PCR. If the PCR test is positive, i.e. the plants contain recombinant plasmids, remove the plants containing recombinant plasmids. The Cas9-F / R primer sequence is shown in SEQ ID NO.16-17. Cas9-F (SEQ ID NO. 16): CGACGAGCACCATCAGGATCTG; Cas9-R (SEQ ID NO. 17): GTGTCAGCACAATGTCCTCGAGG.
[0033] (9) PCR amplification was performed on T1 generation plants without recombinant plasmids using specific primers (including AGO2b-detect-F and AGO2b-detect-R, AGO2ab-2a-detect-F and AGO2ab-2a-detect-R, AGO2ab-2b-detect-F and AGO2ab-2b-detect-R) that spanned the target region. The products were submitted for Sanger sequencing. The results are as follows:Figure 2 As shown in A and B, the mutant MT-ago2b-281 exist AGO2b The first target region has a 3 bp deletion, the second target region has a 2 bp deletion, and the deletion at the second target region results in a frameshift mutation; mutant MT-ago2b-620 No editing occurred in the AGO2a target region, but a 1 bp deletion occurred in the AGO2b DT3 target region. The deletion of AGO2b DT3 resulted in... AGO2b Frameshift mutation; combined with sequencing peak plots, the mutant... MT-ago2b-281 and mutants MT-ago2b-620 The peaks in the target region were all significant single peaks, indicating that both mutants with different editing types were homozygous. These results, confirmed by Sanger sequencing, demonstrate that this study successfully obtained two different editing types. MT-ago2b Homozygous mutants; wherein the nucleotide sequences of the PCR amplification primers are shown in SEQ ID NO.18-23 respectively; AGO2b-detect-F (SEQ ID NO.18): GACCGTGGAAACTACCAACG; AGO2b-detect-R (SEQ ID NO.19): CCAGAAGATTGAGGACGATC; AGO2ab-2a-detect-F (SEQ ID NO.20):GATCAGAGTCCATCATCTCG; AGO2ab-2a-detect-R (SEQ ID NO. 21): GACCTACAGAAGTCCTGCAC; AGO2ab-2b-detect-F (SEQ ID NO.22):GAGTCAGAAGTGTATACAAC; AGO2ab-2b-detect-R (SEQ ID NO. 23): CAAGCAGTGATTGGAACACC.
[0034] (10) Under greenhouse conditions MT-ago2b-281 and MT-ago2b-620 The mutant lines were phenotypically observed, and individual plants were harvested to obtain the T2 generation. For example... Figure 2 As shown in C, MT-ago2b-281 and MT-ago2b-620 The mutants showed no statistically significant differences from wild-type Micro-Tom plants in leaf morphology, plant height, floral organ structure, and fruit development. These results indicate that the growth and development phenotype of the AGO2b loss-of-function mutant is not significantly different from that of wild-type tomatoes, and that knocking out this gene does not hinder the normal growth and development of tomatoes.
[0035] (11) The obtained MT-ago2b-281 , MT-ago2b-620 Wild-type MT seeds were sown and transplanted into greenhouse conditions. Plants with uniform growth were selected and inoculated with wild-type virus TYLCV and the VSR-deficient mutant virus TYLCV-ΔV2. Disease phenotypes were observed, and virus accumulation was detected using Southern blot. A buffer-treated wild-type tomato was used as a blank control (MOCK). Each experiment was repeated three times. Results are as follows: Figure 3 As shown in Figure A, after inoculation with TYLCV, all groups of tomatoes exhibited typical disease phenotypes such as stunted growth, slow development, and curled and shrunken leaves, with the wild type showing more severe symptoms than the wild type. ago2b The mutant was knocked out; after inoculation with TYLCV-ΔV2, no obvious developmental abnormalities were observed in any of the plants; samples were taken 21 days after inoculation, and viral DNA accumulation was detected using Southern Blot; three biological replicates were set up to reduce experimental error, and ImageJ was used to quantify the gray values of the bands, followed by statistical difference analysis using Graphpad. The test results are as follows: Figure 3 Figures B and C show that regardless of whether TYLCV or TYLCV-ΔV2 was administered, compared to wild-type MT-WT, ago2b The viral DNA accumulation in the mutant strains was significantly reduced; more importantly, for TYLCV-ΔV2, viral accumulation was significantly inhibited in WT plants because the function of V2 as a VSR was disrupted. These results indicate that... AGO2b It is a negative regulator in the tomato anti-TYLCV immune pathway. Mutant ago2b-281 , ago2b-620 After inoculation with TYLCV, the viral accumulation was significantly lower than that of the wild type, and the symptoms were also milder; after inoculation with TYLCV-ΔV2, the viral accumulation was significantly lower than that of the wild type. These results indicate that the loss of AGO2b function leads to an increase in plant resistance to TYLCV and has a negative regulatory effect on it.
[0036] Tomatoes only show obvious symptoms after inoculation with TYLCV. To ensure inoculation efficiency, this invention selects to inject the cotyledons at the seedling stage with only two cotyledons, using a high dose of virus. Therefore, the tomato plants are severely affected early on, and although the virus accumulation in the prepared ago2b mutant is significantly lower than that of the wild type, the symptoms are still severe. In actual field production, tomato plants only become ill after being infected by whiteflies in the mid-to-late stages of growth. Compared with the inoculation method of this technical solution, the resistance of tomato plants at this time is much greater than that of tomato seedlings with two cotyledons, and the dose of virus transmitted by whiteflies is also much lower than the dose inoculated in this patent. In this patent, TYLCV inoculation with the ago2b mutant reduces the symptoms, but not significantly, which may be related to the inoculation method. Therefore, it is judged that the resistance performance of the ago2b mutant in actual field use will be better than that in the experimental stage of this invention.
[0037] Because TYLCV-ΔV2 exhibits reduced pathogenicity, its accumulation in tomatoes is lower compared to TYLCV inoculation. Consequently, no obvious symptoms were observed in tomatoes inoculated with TYLCV-ΔV2, indicating a positive correlation between virus accumulation and disease susceptibility. Furthermore, due to the rapid mutation of viruses, resistance genes can lose their effectiveness with the emergence of new viral strains. This application, by knocking out genes that suppress RNAi to enhance plant resistance, provides another avenue for improving resistance, supplementing existing resistance genes and possessing practical application value in actual production.
[0038] In summary, this invention discloses a tomato AGO2b A novel function of the gene, which negatively regulates resistance in tomatoes to wild-type TYLCV and the mutant virus TYLCV-ΔV2, was discovered through knockout. AGO2b The gene can significantly enhance the resistance of tomatoes to TYLCV virus. Simultaneously, this invention provides a genetically stable gene with no exogenous vector residue. ago2b The method for preparing homozygous mutants allows the creation of mutant materials that can be applied to the study of the molecular mechanism of tomato antiviral activity, the creation of disease-resistant germplasm, and the breeding of new varieties. It has significant scientific research value and application prospects in the field of tomato antiviral molecular breeding.
[0039] Although the present invention has been described in detail through the preferred embodiments above, it should be understood that the above description should not be considered as a limitation of the present invention. Various modifications and substitutions to the present invention will be apparent to those skilled in the art after reading the above description. Therefore, the scope of protection of the present invention should be defined by the appended claims.
Claims
1. Tomato AGO2b The application of genes in resistance to Tomato Yellow Leaf Curl Virus (TYLCV) is characterized by, The AGO2b The gene is a disease-susceptibility gene; reduce or knock out the aforementioned gene. AGO2b Gene expression can enhance the resistance of tomatoes to TYLCV; wherein, the... AGO2b The CDS sequence of the gene is shown in SEQ ID NO.
1.
2. The application according to claim 1, characterized in that, The TYLCV includes wild-type TYLCV and / or the VSR-deficient mutant TYLCV-ΔV2.
3. A type of tomato AGO2b The method for preparing gene knockout mutants is characterized by, Includes the following steps: (1) For tomatoes AGO2b Design sgRNA target sequences from gene CDS regions; (2) The sgRNA target sequence is constructed into a knockout vector to obtain a recombinant vector; (3) The recombinant vector was introduced into tomatoes; (4) Screening AGO2b Genetically modified tomato plants with edited genes were screened to obtain homozygous mutants; Among them, the AGO2b The CDS sequence of the gene is shown in SEQ ID NO.
1.
4. The preparation method according to claim 3, characterized in that, The sgRNA target sequence is selected from one or more of SEQ ID NO.2, SEQ ID NO.3 or SEQ ID NO.
5.
5. The preparation method according to claim 3, characterized in that, The knockout vector mentioned in step (2) is selected from pHEE401.
6. The preparation method according to claim 3, characterized in that, The sgRNA target constructed in step (2) uses primers AGO2b-DT1-BsF and AGO2b-DT1-BsR, whose nucleotide sequences are shown in SEQ ID NO.6 and SEQ ID NO.9, respectively.
7. The preparation method according to claim 3, characterized in that, The screening described in step (4) includes: (a) PCR detection of transgenic plants was performed using primer pair Cas9-F / R, the nucleotide sequences of which are shown in SEQ ID NO.16 and SEQ ID NO.17; (b) Select plants from the T1 generation population that do not contain the exogenous Cas9 fragment; (c) Sequencing screening AGO2b Homozygous mutant plants with edited genes.
8. A kind AGO2b Gene knockout mutants are characterized by, Obtained by the preparation method described in any one of claims 3 to 7.
9. As described in claim 8 AGO2b Application of gene knockout mutants in TYLCV resistance breeding.
10. The application according to claim 9, characterized in that, The mutant exhibits significantly enhanced resistance to the viruses TYLCV and / or TYLCV-ΔV2.
